Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Quantify RA Clinical Outcomes Database

The current version of the database includes clinical safety and efficacy information on all biologics as well as newer synthetic DMARDs currently approved or in development for rheumatoid arthritis (RA). Information on older treatment options (MTX and other DMARDs) was included if they are used as active controls.

More Info

Certara’s Best of Blogs 2016

A selection of short essays from our blog, written to empower our customers with modeling and simulation (M&S) and regulatory writing solutions in order to help them solve the toughest drug development problems. Certara staff contributions range in topic from pharmacometrics to systems biology to the growing importance of regulatory writing and sharing clinical trial results.

Author(s): Behtash Bahador, Bernd Wendt, Chris Lovejoy, Christine Yuying Gao, Craig Rayner, Ellen Leinfuss, Karen Rowland Yeo, Lora Killian, Manoranjenni Chetty, Neil Benson, Nirpal Singh Virdee, Patrick Smith, Rik de Greef, Serge Guzy, Steve Sibley, Suzanne Minton, Tatyana Wanderer, Thomas Peyret, Venkateswari Muthukrishnan
More Info

Certara Optimize: Changing the Game in Drug Development

Certara Optimize is a strategic and programmatic approach to drug development that leverages our expertise in drug development, clinical pharmacology, the use of quantitative analysis methods, and regulatory science to optimize decision-making.

Solution: Biosimulation, Drug Development & Regulatory Strategy, PBPK Modeling & Simulation, PK/PD Modeling & Simulation, Regulatory & Medical Writing
More Info

Phoenix IVIVC Toolkit

The Phoenix IVIVC Toolkit provides enhanced tools for in vitro-in vivo correlation studies used by formulation and pharmaceutical scientists to improve the success of BE studies. The IVIVC Toolkit approach requires less assumptions, as compared to other methods, and helps the user define the correlation observed from real in vivo profiles as compared to the dissolution profiles.

Solution: PK/PD Modeling & Simulation
More Info
Learn More
LinkedIn